Corporate social responsibility in countries with mature and emerging pharmaceutical sectors
Fuente:
Redalyc
Enregistré dans:
| Auteur principal: | Anna VOLODINA |
|---|---|
| Format: | Artículo científico |
| Langue: | en |
| Publié: |
Centro de investigaciones y Publicaciones Farmacéuticas
2009
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
An analysis of the warning letters issued by the FDA to pharmaceutical manufacturers regarding misleading health outcomes claims
par: Satabdi CHATTERJEE
Publié: (2012)
par: Satabdi CHATTERJEE
Publié: (2012)
Evaluation of pharmaceutical concerns in Germany: frequency and potential reasons
par: Gabriele GRADL
Publié: (2016)
par: Gabriele GRADL
Publié: (2016)
How drug companies manipulate prescribing behavior
par: Adriane Fugh-Berman
Publié: (2018)
par: Adriane Fugh-Berman
Publié: (2018)
Analysis of medicine advertisement produced in Brazil
par: Lorilei de Fátima Wzorek
Publié: (2007)
par: Lorilei de Fátima Wzorek
Publié: (2007)
Analysis of written advertising material distributed through community pharmacies in Riyadh, Saudi Arabia
par: Sinaa AbdulMohsen AL-AQEEL
Publié: (2013)
par: Sinaa AbdulMohsen AL-AQEEL
Publié: (2013)
Corporate social responsibility and energy efficiency: Empirical evidence from the manufacturing sector of India
par: Baikunthanath Sahoo, et autres
Publié: (2024)
par: Baikunthanath Sahoo, et autres
Publié: (2024)
Exploring food delivery app adoption: Corporate social responsibility and perceived product risk's influence
par: Anna Prisco, et autres
Publié: (2024)
par: Anna Prisco, et autres
Publié: (2024)
Correction to “Sustainability in the pharmaceutics industry – An assessment of ESG maturity and effects of ESG measure implementation on supply chain security”
Publié: (2024)
Publié: (2024)
Corporate social responsibility and capital structure: Moderating effect of culture
par: Cyrine Mhiri, et autres
Publié: (2024)
par: Cyrine Mhiri, et autres
Publié: (2024)
ETHICS IN RESEARCH WITH HUMAN BEINGS: CHALLENGES BETWEEN FORMAL AND REAL
par: P. C. SANTOS
Publié: (2022)
par: P. C. SANTOS
Publié: (2022)
Corporate social responsibility in controversial industries: A literature review and research agenda
par: Linda Jansen, et autres
Publié: (2024)
par: Linda Jansen, et autres
Publié: (2024)
Corporate social responsibility, ownership structure, and corporate governance—An analysis of the Brazilian firm
par: Hyane Correia Forte, et autres
Publié: (2024)
par: Hyane Correia Forte, et autres
Publié: (2024)
Corporate social responsibility and family firm performance: A meta‐analytic review
par: Stephen Oduro, et autres
Publié: (2024)
par: Stephen Oduro, et autres
Publié: (2024)
Corporate violations and bank debt cost: The insurance effect of corporate social responsibility
par: Zhen Li, et autres
Publié: (2024)
par: Zhen Li, et autres
Publié: (2024)
Green Drug Discovery: Leveraging Biodiversity for Sustainable Pharmaceutical Solutions.
par: Singh, Arshdeep, et autres
Publié: (2026)
par: Singh, Arshdeep, et autres
Publié: (2026)
Corporate social performance feedback and corporate social responsibility decoupling in China: The salience of legitimacy and/or efficiency
par: Shan Xue, et autres
Publié: (2024)
par: Shan Xue, et autres
Publié: (2024)
Corporate governance and corporate social responsibility: Evidence from directors' and officers' liability insurance
par: Hui Xia, et autres
Publié: (2024)
par: Hui Xia, et autres
Publié: (2024)
Corporate social responsibility sophistication: Company‐specific drivers among early and late adopters
par: Kyra Kunkel, et autres
Publié: (2024)
par: Kyra Kunkel, et autres
Publié: (2024)
Corporate governance, social responsibility and sustainability commitments by banks: Impacts on credit risk and performance
par: Kittima Ngamvilaikorn, et autres
Publié: (2024)
par: Kittima Ngamvilaikorn, et autres
Publié: (2024)
Copyright Basics. Circular 1.
Publié: (1996)
Publié: (1996)
Corporate social responsibility disclosure and corporate social irresponsibility in emerging economies: Does institutional quality matter?
par: Ali Meftah Gerged, et autres
Publié: (2024)
par: Ali Meftah Gerged, et autres
Publié: (2024)
Do bankers on board fulfill their role? Corporate social responsibility, environmental concerns and firm leverage
par: Saibal Ghosh
Publié: (2024)
par: Saibal Ghosh
Publié: (2024)
Corporate social responsibility in the era of government subsidies: A novel empirical perspective on market competitiveness
par: Adnan Khurshid, et autres
Publié: (2024)
par: Adnan Khurshid, et autres
Publié: (2024)
Corporate social responsibility (CSR) and earnings management: A structured literature review with a focus on contextual factors
par: Patrick Velte
Publié: (2024)
par: Patrick Velte
Publié: (2024)
Women and leadership in non‐listed private companies in an emerging country: An analysis of barriers and facilitators
par: Md Asadul Islam, et autres
Publié: (2024)
par: Md Asadul Islam, et autres
Publié: (2024)
STRATEGIES OF CORPORATE SOCIAL RESPONSIBILITY IN LATIN AMERICA: A CONTENT ANALYSIS IN THE EXTRACTIVE INDUSTRY
par: JOSÉ SATSUMI LÓPEZ-MORALES
Publié: (2017)
par: JOSÉ SATSUMI LÓPEZ-MORALES
Publié: (2017)
Corporate social responsibility practices and value creation through open innovation approach: Evidence from the STOXX Europe 600 Index
par: Francesco Martielli, et autres
Publié: (2024)
par: Francesco Martielli, et autres
Publié: (2024)
Corporate social responsibility and circular economy integration framework within sustainable supply chain management: Building blocks for industry 5.0
par: Bruna da Silva Santiago, et autres
Publié: (2024)
par: Bruna da Silva Santiago, et autres
Publié: (2024)
Corporate social responsibility and competitiveness: a study of Brazilian multinationals
par: Mary Fernanda de Sousa de Melo
Publié: (2022)
par: Mary Fernanda de Sousa de Melo
Publié: (2022)
SMART-assisted discovery of scalaranes from the marine sponge Lendenfeldia sp. and its anti-osteoclastogenesis activity.
par: Pham, Quoc-Vu, et autres
Publié: (2026)
par: Pham, Quoc-Vu, et autres
Publié: (2026)
Genome analysis-led discovery of antimicrobial and herbicidal cytochalasans from the cold-seep-sourced endozoic Curvularia verruculosa CS-129.
par: Hu, Xue-Yi, et autres
Publié: (2026)
par: Hu, Xue-Yi, et autres
Publié: (2026)
Repurposing Lamivudine: A novel therapeutic strategy for ischemic stroke targeting the glycolytic enzyme Pgk1.
par: Liu, Jingjing, et autres
Publié: (2026)
par: Liu, Jingjing, et autres
Publié: (2026)
Irresponsible to others but responsible to me: Testing employees' responses to external corporate social irresponsibility and internal corporate social responsibility
par: Cen April Yue, et autres
Publié: (2024)
par: Cen April Yue, et autres
Publié: (2024)
Correction to “Corporate Culture in Small and Medium Enterprises: Application of Corporate Social Responsibility Theory”
Publié: (2025)
Publié: (2025)
Perceived Corporate Social Responsibility and Employee Engagement: Organizational Identification and Corporate Volunteering Climate
par: Junyi Zuo, et autres
Publié: (2025)
par: Junyi Zuo, et autres
Publié: (2025)
Correction to: The Involvement of Telecommunication Industry in the Road to Corporate Sustainability and Corporate Social Responsibility Commitment
Publié: (2025)
Publié: (2025)
Corporate Social Responsibility and Corporate Tax Avoidance in Europe: Evidence From the Anti‐Tax Avoidance Directives
par: Alessandro Migliavacca
Publié: (2026)
par: Alessandro Migliavacca
Publié: (2026)
When Corporations Nudge for Good: Examining the Effectiveness of Corporate Social Marketing Initiatives in Influencing Intention to Change
par: Paul Blaise Issock Issock
Publié: (2026)
par: Paul Blaise Issock Issock
Publié: (2026)
Exploring the Impacts of ESG Disclosure on Corporate Financing Constraints: A Perspective of Classifying Corporate Carbon Emissions
par: Yihui Tian, et autres
Publié: (2025)
par: Yihui Tian, et autres
Publié: (2025)
Corporate hypocrisy and ESG rating divergence
par: Renxiang He, et autres
Publié: (2024)
par: Renxiang He, et autres
Publié: (2024)
Documents similaires
-
An analysis of the warning letters issued by the FDA to pharmaceutical manufacturers regarding misleading health outcomes claims
par: Satabdi CHATTERJEE
Publié: (2012) -
Evaluation of pharmaceutical concerns in Germany: frequency and potential reasons
par: Gabriele GRADL
Publié: (2016) -
How drug companies manipulate prescribing behavior
par: Adriane Fugh-Berman
Publié: (2018) -
Analysis of medicine advertisement produced in Brazil
par: Lorilei de Fátima Wzorek
Publié: (2007) -
Analysis of written advertising material distributed through community pharmacies in Riyadh, Saudi Arabia
par: Sinaa AbdulMohsen AL-AQEEL
Publié: (2013)